EWM
Essex Woodlands Management Portfolio holdings
AUM $279M
1-Year Return
29.39%
This Quarter Return
+18.35%
1 Year Return
+29.39%
3 Year Return
+195.65%
5 Year Return
+90.32%
10 Year Return
+273.6%
AUM
$457M
AUM Growth
-$96.3M
(-17%)
Cap. Flow
-$197M
Cap. Flow
% of AUM
-43.01%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
1
Increased
–
Reduced
1
Closed
1
Top Buys
| 1 |
EyePoint Pharmaceuticals
EYPT
|
+$10.5M |
Top Sells
| 1 |
ABMD
Abiomed Inc
ABMD
|
+$129M |
| 2 |
ENTL
Entellus Medical, Inc. Common Stock
ENTL
|
+$77.6M |
Sector Composition
| 1 | Healthcare | 97.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Axogen
AXGN
$774M
| $135M | 29.64% |
3,711,111
| – | – |
|
|
RVNC
2
DELISTED
Revance Therapeutics, Inc.
RVNC
| $118M | 25.9% |
3,842,047
| – | – |
|
|
CORI
3
DELISTED
Corium International, Inc.
CORI
| $107M | 23.48% |
9,353,304
| – | – |
|
|
ABMD
4
DELISTED
Abiomed Inc
ABMD
| $58.7M | 12.85% |
201,818
-445,000
| -69% | -$129M |
|
5
MediciNova
MNOV
$59.8M
| $12M | 2.62% |
1,170,370
| – | – |
|
|
ELGX
6
DELISTED
Endologix Inc
ELGX
| $11.6M | 2.53% |
125,747
| – | – |
|
|
7
EyePoint Pharmaceuticals
EYPT
$940M
| $10.5M | 2.3% |
+860,632
| New | +$10.5M |
|
8
Gyre Therapeutics
GYRE
$685M
| $2.11M | 0.46% |
10,483
| – | – |
|
|
ACUR
9
DELISTED
Acura Pharmaceuticals Inc
ACUR
| $998K | 0.22% |
1,956,397
| – | – |
|
|
ENTL
10
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
| – | – |
-3,231,656
| Closed | -$77.6M |
|